These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
174 related items for PubMed ID: 24279419
1. Large-scale analysis of somatic hypermutations in antibodies reveals which structural regions, positions and amino acids are modified to improve affinity. Burkovitz A, Sela-Culang I, Ofran Y. FEBS J; 2014 Jan; 281(1):306-19. PubMed ID: 24279419 [Abstract] [Full Text] [Related]
2. Trends in antibody sequence changes during the somatic hypermutation process. Clark LA, Ganesan S, Papp S, van Vlijmen HW. J Immunol; 2006 Jul 01; 177(1):333-40. PubMed ID: 16785529 [Abstract] [Full Text] [Related]
3. Why does somatic hypermutation by AID require transcription of its target genes? Storb U. Adv Immunol; 2014 Jul 01; 122():253-77. PubMed ID: 24507160 [Abstract] [Full Text] [Related]
4. Contribution of heavy chain junctional amino acid diversity to antibody affinity among p-azophenylarsonate-specific antibodies. Parhami-Seren B, Margolies MN. J Immunol; 1996 Sep 01; 157(5):2066-72. PubMed ID: 8757328 [Abstract] [Full Text] [Related]
5. Analysis of 6912 unselected somatic hypermutations in human VDJ rearrangements reveals lack of strand specificity and correlation between phase II substitution rates and distance to the nearest 3' activation-induced cytidine deaminase target. Ohm-Laursen L, Barington T. J Immunol; 2007 Apr 01; 178(7):4322-34. PubMed ID: 17371989 [Abstract] [Full Text] [Related]
6. Critical binding site amino acids of anti-Z-DNA single chain Fv molecules. Role of heavy and light chain CDR3 and relationship to autoantibody activity. Polymenis M, Stollar BD. J Immunol; 1994 Jun 01; 152(11):5318-29. PubMed ID: 8189049 [Abstract] [Full Text] [Related]
9. Structural elements controlling anti-DNA antibody affinity and their relationship to anti-phosphorylcholine activity. Pewzner-Jung Y, Simon T, Eilat D. J Immunol; 1996 Apr 15; 156(8):3065-73. PubMed ID: 8609430 [Abstract] [Full Text] [Related]
12. Recombinase-mediated cassette exchange as a novel method to study somatic hypermutation in Ramos cells. Baughn LB, Kalis SL, MacCarthy T, Wei L, Fan M, Bergman A, Scharff MD. mBio; 2011 Apr 15; 2(5):. PubMed ID: 21990614 [Abstract] [Full Text] [Related]
13. Activation-induced cytidine deaminase turns on somatic hypermutation in hybridomas. Martin A, Bardwell PD, Woo CJ, Fan M, Shulman MJ, Scharff MD. Nature; 2002 Feb 14; 415(6873):802-6. PubMed ID: 11823785 [Abstract] [Full Text] [Related]
14. Structural properties and mutation patterns of anti-nucleosome monoclonal antibodies are similar to those of anti-DNA antibodies. Brard F, Jovelin F, Petit S, Tron F, Gilbert D. Eur J Immunol; 1996 Jul 14; 26(7):1587-94. PubMed ID: 8766565 [Abstract] [Full Text] [Related]
15. Targets of somatic hypermutation within immunoglobulin light chain genes in zebrafish. Marianes AE, Zimmerman AM. Immunology; 2011 Feb 14; 132(2):240-55. PubMed ID: 21070232 [Abstract] [Full Text] [Related]
16. Molecular mechanism of immunoglobulin V-region diversification regulated by transcription and RNA metabolism in antigen-driven B cells. Sakaguchi N, Maeda K, Kuwahara K. Scand J Immunol; 2011 Jun 14; 73(6):520-6. PubMed ID: 21388430 [Abstract] [Full Text] [Related]
17. DNA binding by the VH domain of anti-Z-DNA antibody and its modulation by association of the VL domain. Chen Y, Stollar BD. J Immunol; 1999 Apr 15; 162(8):4663-70. PubMed ID: 10202006 [Abstract] [Full Text] [Related]
18. Domain interactions and antigen binding of recombinant anti-Z-DNA antibody variable domains. The role of heavy and light chains measured by surface plasmon resonance. Polymenis M, Stollar BD. J Immunol; 1995 Mar 01; 154(5):2198-208. PubMed ID: 7868893 [Abstract] [Full Text] [Related]
19. The critical role of arginine residues in the binding of human monoclonal antibodies to cardiolipin. Giles I, Lambrianides N, Latchman D, Chen P, Chukwuocha R, Isenberg D, Rahman A. Arthritis Res Ther; 2005 Mar 01; 7(1):R47-56. PubMed ID: 15642142 [Abstract] [Full Text] [Related]
20. Tolerance of single, but not multiple, amino acid replacements in antibody VH CDR 2: a means of minimizing B cell wastage from somatic hypermutation? Brown M, Rittenburg MB, Chen C, Roberts VA. J Immunol; 1996 May 01; 156(9):3285-91. PubMed ID: 8617951 [Abstract] [Full Text] [Related] Page: [Next] [New Search]